RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
BERTOLOTTO A
Collezione AOU San Luigi di Orbassano
Items : 139
In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting. in Journal of neurology / J Neurol. 2024 Sep 23. doi: 10.1007/s00415-024-12701-w.
2024
AOU San Luigi di Orbassano
Malucchi S; Bava CI; Valentino P; Martire S; Lo Re M; Bertolotto A; Di Sapio A;
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT). in Journal of neurology / J Neurol. 2024 May;271(5):2182-2194. doi: 10.1007/s00415-024-12214-6. Epub 2024 Feb 16.
2024
AOU San Luigi di Orbassano
Bianchi A; Matranga D; Patti F; Maniscalco L; Pilotto S; Di Filippo M; Zaffaroni M; Annovazzi P; Bertolotto A; Gasperini C; Quartuccio E; Centonze D; Fantozzi R; Gajofatto A; Gobbin F; Landi D; Granella F; Buccafusca M; Marfia GA; Chisari C; Naldi P; Bergamaschi R; Greco G; Zarbo IR; Rizzo V; Ulivelli M; Bezzini D; Florio L; Turazzini M; et alii...
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study. in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics / Neurotherapeutics. 2024 Jul;21(4):e00363. doi: 10.1016/j.neurot.2024.e00363. Epub 2024 May 7.
2024
AOU San Luigi di Orbassano
Chisari CG; Aguglia U; Amato MP; Bergamaschi R; Bertolotto A; Bonavita S; Morra VB; Cavalla P; Cocco E; Conte A; Cottone S; De Luca G; Di Sapio A; Filippi M; Gallo A; Gasperini C; Granella F; Lus G; Maimone D; Maniscalco GT; Marfia G; Moiola L; Paolicelli D; Pesci I; Ragonese P; Rovaris M; Salemi G; Solaro C; Totaro R; et alii...
Prevalence of elevated sNFL in a real-world setting: Results on 908 patients with different multiple sclerosis types and treatment conditions. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2024 Aug;88:105748. doi: 10.1016/j.msard.2024.105748. Epub 2024 Jun 29.
2024
AOU San Luigi di Orbassano
Bava CI; Valentino P; Malucchi S; Bottero R; Martire S; Sapio AD; Bertolotto A;
Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Sep;77:104893. doi: 10.1016/j.msard.2023.104893. Epub 2023 Jul 16.
2023
AO Cuneo
AOU San Luigi di Orbassano
Di Sapio A; Oggero A; Malentacchi M; Sperli F; Capobianco M; Martire S; Bava CI; Malucchi S; Valentino P; Bertolotto A;
Applying multidimensional computerized adaptive testing to the MSQOL-54: a simulation study. in Health and quality of life outcomes / Health Qual Life Outcomes. 2023 Jun 25;21(1):61. doi: 10.1186/s12955-023-02152-8.
2023
AOU San Luigi di Orbassano
Giordano A; Testa S; Bassi M; Cilia S; Bertolotto A; Quartuccio ME; Pietrolongo E; Falautano M; Grobberio M; Niccolai C; Allegri B; Viterbo RG; Confalonieri P; Giovannetti AM; Cocco E; Grasso MG; Lugaresi A; Ferriani E; Nocentini U; Zaffaroni M; De Livera A; Jelinek G; Solari A; Rosato R;
Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Dec;80:105131. doi: 10.1016/j.msard.2023.105131. Epub 2023 Nov 7.
2023
AOU San Luigi di Orbassano
Toscano S; Oteri V; Chisari CG; Finocchiaro C; Lo Fermo S; Valentino P; Bertolotto A; Zappia M; Patti F;
Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study. in Neurology and therapy / Neurol Ther. 2023 Aug;12(4):1375-1383. doi: 10.1007/s40120-023-00481-w. Epub 2023 May 11.
2023
AO Cuneo
AOU Città della Salute di Torino
AOU San Luigi di Orbassano
Capobianco MA; Bertolotto A; Pautasso M; Valentino P; Martire S; Sala A; Malentacchi M; Sperli F; Malucchi S; Bruschi N;
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Sep 30:jnnp-2022-329657. doi: 10.1136/jnnp-2022-329657.
2022
AOU San Luigi di Orbassano
Rasia S; Salemi G; Signoriello E; Vitetta F; Totaro R; Sormani MP; Amato MP; Marfia GA; Malucchi S; Margoni M; Mataluni G; Mirabella M; Moiola L; Nicoletti CG; Nociti V; Patti F; Pinardi F; Portaccio E; Pozzilli C; Ragonese P; De Luca G; Di Filippo M; Di Lemme S; Fantozzi R; Ferraro D; Ferraro E; Gallo A; Gasperini C; Granella F; et alii...
NURR1-deficient mice have age- and sex-specific behavioral phenotypes. in Journal of neuroscience research / J Neurosci Res. 2022 Sep;100(9):1747-1754. doi: 10.1002/jnr.25067. Epub 2022 May 20.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Capobianco MA; Tempia F; Hoxha E; De Francia S; Allegra S; Chiara F; Martire S; Montarolo F; Bertolotto A;
sNFL applicability as additional monitoring tool in natalizumab extended interval dosing regimen for RRMS patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2022 Nov;67:104176. doi: 10.1016/j.msard.2022.104176. Epub 2022 Sep 14.
2022
AO Cuneo
AOU San Luigi di Orbassano
Bertolotto A; Capobianco MA; Bava CI; Martire S; Malucchi S; Valentino P;
The Selective Agonist for Sphingosine-1-Phosphate Receptors Siponimod Increases the Expression Level of NR4A Genes in Microglia Cell Line. in Current issues in molecular biology / Curr Issues Mol Biol. 2022 Mar 7;44(3):1247-1256. doi: 10.3390/cimb44030083.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Bertolotto A; Capobianco MA; Valverde S; Valentino P; Marnetto F; Martire S; Montarolo F;
The impact of pre-freezing storage time and temperature on gene expression of blood collected in EDTA tubes. in Molecular biology reports / Mol Biol Rep. 2022 Jun;49(6):4709-4718. doi: 10.1007/s11033-022-07320-5. Epub 2022 Mar 12.
2022
ASL Torino 4
AOU San Luigi di Orbassano
Bertolotto A; Capobianco M; Mirabile L; Marnetto F; Valentino P; Martire S;
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study. in Journal of neurology / J Neurol. 2022 Feb;269(2):933-944. doi: 10.1007/s00415-021-10676-6. Epub 2021 Jun 28.
2022
AOU Città della Salute di Torino
ASL Cuneo 1
AOU San Luigi di Orbassano
Lepore V; Solaro C; Lus G; Maimone D; Bergamaschi R; Granella F; Di Sapio A; Bertolotto A; Totaro R; Vianello M; Cavalla P; Bellantonio P; De Luca G; Cottone S; Rovaris M; Pesci I; Amato MP; Ferrò MT; Gasperini C; Maniscalco GT; Aguglia U; Sola P; Conte A; Lugaresi A; Salemi G; Paolicelli D; Iaffaldano P; Zaffaroni M; Brescia Morra V; et alii...
Viability of a MSQOL-54 general health-related quality of life score using bifactor model. in Health and quality of life outcomes / Health Qual Life Outcomes. 2021 Sep 25;19(1):224. doi: 10.1186/s12955-021-01857-y.
2021
AOU Città della Salute di Torino
AOU San Luigi di Orbassano
Rosato R; Jelinek G; Solari A; De Livera A; Zaffaroni M; Ferriani E; Nocentini U; Lugaresi A; Grasso MG; Cocco E; Giovannetti AM; Confalonieri P; Viterbo RG; Allegri B; Niccolai C; Grobberio M; Falautano M; Pietrolongo E; Quartuccio ME; Bertolotto A; Cilia S; Bassi M; Giordano A; Testa S;
Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2021 Sep;54:103090. doi: 10.1016/j.msard.2021.103090. Epub 2021 Jun 17.
2021
AOU San Luigi di Orbassano
Valentino P; Marnetto F; Martire S; Malucchi S; Bava CI; Popovic M; Bertolotto A;
Fingolimod as first-line treatment in pediatric-onset multiple sclerosis: a case report. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2021 May;42(Suppl 1):25-28. doi: 10.1007/s10072-020-05027-8. Epub 2021 Mar 12.
2021
AOU San Luigi di Orbassano
Malucchi S; Bertolotto A; Capobianco M;
Exposure to fine particulate matter (PM(2.5)) hampers myelin repair in a mouse model of white matter demyelination. in Neurochemistry international / Neurochem Int. 2021 May;145:104991. doi: 10.1016/j.neuint.2021.104991. Epub 2021 Feb 12.
2021
AOU San Luigi di Orbassano
Bollati V; Boda E; Buffo A; Bertolotto A; Cattaneo A; Pini A; Rovelli S; Montarolo F; Parolisi R;
A First Phenotypic and Functional Characterization of Placental Extracellular Vesicles from Women with Multiple Sclerosis. in International journal of molecular sciences / Int J Mol Sci. 2021 Mar 12;22(6):2875. doi: 10.3390/ijms22062875.
2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Bertolotto A; Benedetto C; Botta G; Camussi G; Deregibus MC; Chiabotto G; Bruno S; Frezet F; Marozio L; Sforza ML; Perga S; Spadaro M; Montarolo F; Martire S;
Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation. in Brain pathology (Zurich, Switzerland) / Brain Pathol. 2021 Mar;31(2):283-296. doi: 10.1111/bpa.12906. Epub 2020 Nov 18.
2021
AOU San Luigi di Orbassano
Bertolo J; Magliozzi R; Bono G; Bonaldo B; Martire S; Perga S; Montarolo F; Bertolotto A;
Coverage of the requirements of first and second level stroke unit in Italy. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2021 Mar;42(3):1073-1079. doi: 10.1007/s10072-020-04616-x. Epub 2020 Jul 31.
2021
AOU San Luigi di Orbassano
De Michele G; Melis M; Onofrj M; Manganotti P; Gambardella A; Tambasco N; Vecchio M; Bertolotto A; Siciliano G; Altavista MC; Ragno M; Agostoni E; Bandini F; Zini A; Paolicelli D; Gandolfo C; Toni D; Bandettini di Poggio M; Reale N; Tedeschi G; Mancardi G;
Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis. in Neurology / Neurology. 2021 Jan 20:10.1212/WNL.0000000000011461. doi: 10.1212/WNL.0000000000011461.
2021
ASL Città di Torino
AOU San Luigi di Orbassano
Repice AM; Ciceri F; Innocenti C; Signori A; Angelucci E; Uccelli A; Comi G; Bertolotto A; Zimatore GB; Scimè R; Frau J; Greco R; De Gobbi M; Gualandi F; Cottone S; Amato MP; Lucia M; Capobianco M; Mariottini A; Inglese M; Massacesi L; Boffa G; Sormani MP; Saccardi R; Mancardi G;
Analysis of the Gadolinium retention in the Experimental Autoimmune Encephalomyelitis (EAE) murine model of Multiple Sclerosis. in Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) / J Trace Elem Med Biol. 2021 Dec;68:126831. doi: 10.1016/j.jtemb.2021.126831. Epub 2021 Aug 2.
2021
AOU San Luigi di Orbassano
Furlan C; Montarolo F; Di Gregorio E; Parolisi R; Atlante S; Buffo A; Bertolotto A; Aime S; Gianolio E;
HGF and MET: From Brain Development to Neurological Disorders. in Frontiers in cell and developmental biology / Front Cell Dev Biol. 2021 Jun 9;9:683609. doi: 10.3389/fcell.2021.683609. eCollection 2021.
2021
AOU San Luigi di Orbassano
Desole C; Gallo S; Vitacolonna A; Montarolo F; Bertolotto A; Vivien D; Comoglio P; Crepaldi T;
Concomitant brain arterial and venous thrombosis in a COVID-19 patient. in European journal of neurology / Eur J Neurol. 2020 Sep;27(9):e38-e39. doi: 10.1111/ene.14380. Epub 2020 Jun 30.
2020
AOU San Luigi di Orbassano
Bertolotto A; Veltri A; Perboni A; Demichelis S; Angelino V; Gned D; Malentacchi M; Capobianco M;
Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years. in Multiple sclerosis journal - experimental, translational and clinical / Mult Scler J Exp Transl Clin. 2020 Dec 18;6(4):2055217320972137. doi: 10.1177/2055217320972137. eCol
2020
AOU San Luigi di Orbassano
Firmino I; Cavalier SJ; Freedman MS; Bertolotto A; Boster A; Horáková D; Jacobs AK; Thangavelu K; Daizadeh N; Poole EM; Baker DP; Margolin DH; Ziemssen T;
Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Oct;41(10):2843-2851. doi: 10.1007/s10072-020-04380-y. Epub 2020 Apr 21.
2020
AOU San Luigi di Orbassano
Nica M; Colombo D; Capobianco M; Iaffaldano P; Carotenuto A; Prosperini L; Sangalli F; Bertolotto A; Morra VB; Pozzilli C; Comi G; Rizzoli S; Trojano M;
In vivo silencing of miR-125a-3p promotes myelin repair in models of white matter demyelination. in Glia / Glia. 2020 Oct;68(10):2001-2014. doi: 10.1002/glia.23819. Epub 2020 Mar 12.
2020
AOU San Luigi di Orbassano
Abbracchio MP; Buffo A; Bertolotto A; Perga S; Montarolo F; Giorgi C; Negri C; Parolisi R; Boda E; Marangon D; Lecca D;
Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2020 Nov;46:102592. doi: 10.1016/j.msard.2020.102592. Epub 2020 Oct 21.
2020
AOU San Luigi di Orbassano
Solaro C; Capobianco M; Bertolotto A; Lo Re M; Masuccio FG;
The transcription factor Nurr1 is upregulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice. in Disease models & mechanisms / Dis Model Mech. 2020 May 15;13(5):dmm043513. doi: 10.1242/dmm.043513.
2020
AOU San Luigi di Orbassano
Chiò A; Fuda G; Calvo A; Signorino E; Gionchiglia N; Iannello A; Cutrupi S; Martire S; Perga S; Guglielmotto M; Montarolo F; Boido M; Valsecchi V; Bertolotto A; Vercelli A;
Assessing measurement invariance of MSQOL-54 across Italian and English versions. in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation / Qual Life Res. 2020 Mar;29(3):783-791. doi: 10.1007/s11136-019-02352-0. Epub 2019 Nov 9.
2020
AOU San Luigi di Orbassano
Zaffaroni M; Nocentini U; Ferriani E; Lugaresi A; Grasso MG; Cocco E; Giovannetti AM; Confalonieri P; Viterbo RG; Allegri B; Niccolai C; Grobberio M; Falautano M; Pietrolongo E; Quartuccio ME; Bertolotto A; Cilia S; Bassi M; Testa S; Giordano A; De Livera A; Jelinek G; Solari A; Rosato R;
Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing-Remitting Multiple Sclerosis Patients. in Neurology and therapy / Neurol Ther. 2020 Dec;9(2):197-203. doi: 10.1007/s40120-020-00200-9. Epub 2020 Jun 16.
2020
AOU San Luigi di Orbassano
De Gobbi M; Capobianco M; Mirabile L; Martire S; Bertolotto A; Cilloni D;
Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies. in Neurology and therapy / Neurol Ther. 2020 Dec;9(2):443-457. doi: 10.1007/s40120-020-00191-7. Epub 2020 May 14.
2020
AOU San Luigi di Orbassano
Singer BA; Ziemssen T; Mitsikostas DD; Miller T; Kornek B; Izquierdo G; Hunter SF; Honeycutt WD; Comi G; Havrdova EK; Celius EG; Arroyo R; Bertolotto A; Chung L; Daizadeh N; Afsar S; Hashemi L; Senior P;
TNFAIP3 Deficiency Affects Monocytes, Monocytes-Derived Cells and Microglia in Mice. in International journal of molecular sciences / Int J Mol Sci. 2020 Apr 18;21(8):2830. doi: 10.3390/ijms21082830.
2020
AOU San Luigi di Orbassano
Martire S; Spadaro M; Tessarolo C; Perga S; Montarolo F; Bertolotto A;
NURR1 Impairment in Multiple Sclerosis. in International journal of molecular sciences / Int J Mol Sci. 2019 Sep 30;20(19):4858. doi: 10.3390/ijms20194858.
2019
AOU San Luigi di Orbassano
Bertolotto A; Perga S; Martire S; Montarolo F;
eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2019 May;25(6):856-866. doi: 10.1177/1352458518774935. Epub 2018 May 15.
2019
AOU San Luigi di Orbassano
Toscano A; Rossi I; Grasso MG; Lugaresi A; Pietrolongo E; Chisari CG; Patti F; Confalonieri P; Giovannetti AM; Scavelli F; Testa S; Bertolotto A; Rosato R; Loera B; Giordano A; Solari A;
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2019 Mar;25(3):399-407. doi: 10.1177/1352458518754364. Epub 2018 Jan 24.
2019
AOU San Luigi di Orbassano
Scarpini E; Costantino G; Scandellari C; Righini I; Bellantonio P; Amato MP; Milani N; Miante S; Gallo P; Margoni M; Capobianco M; Bertolotto A; D'Amico E; Patti F; Fanelli F; Simone M; Iaffaldano P; Fenu G; Lorefice L; Moiola L; Zaffaroni M; Baroncini D; Bergamaschi R; Mallucci G; Comi G; Ghezzi A;
NURR1 deficiency is associated to ADHD-like phenotypes in mice. in Translational psychiatry / Transl Psychiatry. 2019 Aug 27;9(1):207. doi: 10.1038/s41398-019-0544-0.
2019
AOU San Luigi di Orbassano
De Francia S; Allegra S; Brescia I; Spadaro M; Perga S; Martire S; Montarolo F; Bertolotto A;
Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod. in European journal of neurology / Eur J Neurol. 2019 Apr;26(4):667-672. doi: 10.1111/ene.13875. Epub 2018 Dec 22.
2019
AOU San Luigi di Orbassano
Panzica G; Lo Re M; Caldano M; Brescia F; Martire S; Montarolo F; Perga S; Bertolotto A;
Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings. in Frontiers in neurology / Front Neurol. 2019 Mar 22;10:253. doi: 10.3389/fneur.2019.00253. eCollection 2019.
2019
AOU San Luigi di Orbassano
Oreja-Guevara C; Meuth SG; Limmroth V; Lee JM; Habek M; Cruz DD; de Seze J; Celius EG; Boster A; Bertolotto A; LaGanke C; Bass AD; Traboulsee A; Carruthers R; Barclay K; Pagnotta P; Vos C; Ziemssen T; Baker DP; Wijmeersch BV;
Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2018 Sep 13;5(6):e498. doi: 10.1212/NXI.0000000000000498. eCollect
2018
AOU San Luigi di Orbassano
Marcinnò A; Marnetto F; Valentino P; Martire S; Balbo A; Drago A; Leto M; Capobianco M; Panzica G; Bertolotto A;
Correction to: Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2018 Feb;39(2):395. doi: 10.1007/s10072-017-3226-9.
2018
AOU San Luigi di Orbassano
Amato MP; Bertolotto A; Brunelli R; Cavalla P; Goretti B; Marrosu MG; Patti F; Pozzilli C; Provinciali L; Rizzo N; Strobelt N; Tedeschi G; Trojano M; Comi G;
Authors' Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®). in Neurology and therapy / Neurol Ther. 2018 Dec;7(2):391-393. doi: 10.1007/s40120-018-0116-x. Epub 2018 Nov 10.
2018
AOU San Luigi di Orbassano
Annovazzi P; Bertolotto A; Brescia Morra V; Gasperini C; Montanari E; Navarra P; Patti F; Pia Sormani M; Ghezzi A;
Access to social security benefits among multiple sclerosis patients in Italy: A cross-sectional study. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2018 Aug;24:107-112. doi: 10.1016/j.msard.2018.06.016. Epub 2018 Jun 23.
2018
AOU San Luigi di Orbassano
Bo M; Charrier L; Bartalini S; Benvenuti M; Oggero A; Ulivelli M; Gabbrielli M; Bertolotto A; Gianino MM;
Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study. in Journal of neurology / J Neurol. 2018 Aug;265(8):1850-1859. doi: 10.1007/s00415-018-8916-6. Epub 2018 Jun 14.
2018
AOU San Luigi di Orbassano
Mallucci G; Annovazzi P; Miante S; Torri-Clerici V; Matta M; La Gioia S; Cavarretta R; Mantero V; Costantini G; D'Ambrosio V; Zaffaroni M; Ghezzi A; Perini P; Rossi S; Bertolotto A; Rottoli MR; Rovaris M; Balgera R; Cavalla P; Montomoli C; Bergamaschi R;
The Footprints of Poly-Autoimmunity: Evidence for Common Biological Factors Involved in Multiple Sclerosis and Hashimoto's Thyroiditis. in Frontiers in immunology / Front Immunol. 2018 Feb 20;9:311. doi: 10.3389/fimmu.2018.00311. eCollection 2018.
2018
AOU San Luigi di Orbassano
Perga S; Martire S; Montarolo F; Giordani I; Spadaro M; Bono G; Corvisieri S; Messuti I; Panzica G; Orlandi F; Bertolotto A;
A whole-exome sequencing approach in multiplex Italian multiple sclerosis families to identify new genes involved in the disease in Multiple Sclerosis Journal
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Mascia E; Zauli A; Guaschino C; Ferrè L; Sorosina M; Osiceanu AM; Santoro S; Peroni S; Biancolini D; Bonfiglio S; Lazarevic D; Barizzone N; Basagni C; Zuccalà M; Vecchio D; Liguori M; Guerini FM; Meola G; Comi G; Tonon G; Esposito F; D'Alfonso S; Martinelli Boneschi F; Moccia M; Frau J; Carotenuto A; Coghe G; Barbero P; Frontoni M; et alii...
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD). in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2017 Oct;38(Suppl 2):231-236. doi: 10.1007/s10072-017-3027-1.
2017
AOU San Luigi di Orbassano
Franciotta D; Gastaldi M; Sala A; Andreetta F; Rinaldi E; Ruggieri M; Leante R; Costa G; Biagioli T; Massacesi L; Bazzigaluppi E; Fazio R; Mariotto S; Ferrari S; Galloni E; Perini F; Zardini E; Zuliani L; Zoccarato M; Giometto B; Bertolotto A;
Cerebrospinal fluid analysis and the determination of oligoclonal bands. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2017 Oct;38(Suppl 2):217-224. doi: 10.1007/s10072-017-3034-2.
2017
AOU San Luigi di Orbassano
Gastaldi M; Zardini E; Leante R; Ruggieri M; Costa G; Cocco E; De Luca G; Cataldo I; Biagioli T; Ballerini C; Castellazzi M; Fainardi E; Pettini P; Zaffaroni M; Giunti D; Capello E; Bernardi G; Ciusani E; Giannotta C; Nobile-Orazio E; Bazzigaluppi E; Passerini G; Bedin R; Sola P; Brivio R; Cavaletti G; Sala A; Bertolotto A; Desina G; et alii...
Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2017 Oct;38(10):1849-1858. doi: 10.1007/s10072-017-3081-8. Epub 2017 Aug 2.
2017
AOU San Luigi di Orbassano
Amato MP; Bertolotto A; Brunelli R; Cavalla P; Goretti B; Marrosu MG; Patti F; Pozzilli C; Provinciali L; Rizzo N; Strobelt N; Tedeschi G; Trojano M; Comi G;
Long-term disability progression in primary progressive multiple sclerosis: a 15-year study. in Brain : a journal of neurology / Brain. 2017 Nov 1;140(11):2814-2819. doi: 10.1093/brain/awx250.
2017
AOU San Luigi di Orbassano
Rocca MA; Sormani MP; Rovaris M; Caputo D; Ghezzi A; Montanari E; Bertolotto A; Laroni A; Bergamaschi R; Martinelli V; Comi G; Filippi M;
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-?1a using RebiSmart™-the FUTURE study. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2017 Nov;38(11):1999-2005. doi: 10.1007/s10072-017-3091-6. Epub 2017 Aug 22.
2017
AOU San Luigi di Orbassano
Ghezzi A; Bianchi A; Baroncini D; Bertolotto A; Malucchi S; Bresciamorra V; Lanzillo R; Milani N; Martinelli V; Patti F; Chisari C; Rottoli M; Simone M; Paolicelli D; Visconti A;
Computerized posturography is more sensitive than clinical Romberg Test in detecting postural control impairment in minimally impaired Multiple Sclerosis patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2017 May;14:51-55. doi: 10.1016/j.msard.2017.03.008. Epub 2017 Mar 23.
2017
AOU San Luigi di Orbassano
Melillo F; Di Sapio A; Martire S; Malentacchi M; Matta M; Bertolotto A;
Aquaporin-4 antibody titration in NMO patients treated with rituximab: A retrospective study. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2016 Dec 15;4(2):e317. doi: 10.1212/NXI.0000000000000317. eCollect
2017
AOU San Luigi di Orbassano
Valentino P; Marnetto F; Granieri L; Capobianco M; Bertolotto A;
Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients. in Journal of immunological methods / J Immunol Methods. 2017 Jun;445:53-58. doi: 10.1016/j.jim.2017.03.008. Epub 2017 Mar 12.
2017
AOU San Luigi di Orbassano
Marnetto F; Valentino P; Caldano M; Bertolotto A;
High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study. in Neurology and therapy / Neurol Ther. 2017 Jun;6(1):145-152. doi: 10.1007/s40120-016-0058-0. Epub 2016 Dec 3.
2017
AOU San Luigi di Orbassano
Malucchi S; Capobianco M; Lo Re M; Malentacchi M; di Sapio A; Matta M; Sperli F; Bertolotto A;
A20 in Multiple Sclerosis and Parkinson's Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways? in Neurotoxicity research / Neurotox Res. 2017 Jul;32(1):1-7. doi: 10.1007/s12640-017-9724-y. Epub 2017 Mar 23.
2017
AOU San Luigi di Orbassano
ASL Città di Torino
Chiò A; Bertolotto A; Leotta D; Marchet A; Fuda G; Calvo A; Navone ND; Montarolo F; Martire S; Perga S;
Erratum to: Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients. in Neurotoxicity research / Neurotox Res. 2017 Feb;31(2):317. doi: 10.1007/s12640-016-9685-6.
2017
AOU San Luigi di Orbassano
ASL Città di Torino
Leotta D; Bertolotto A; Marchet A; Navone DN; Martire S; Perga S; Montarolo F;
A Comprehensive Review on Copemyl(®). in Neurology and therapy / Neurol Ther. 2017 Dec;6(2):161-173. doi: 10.1007/s40120-017-0079-3. Epub 2017 Jul 31.
2017
AOU San Luigi di Orbassano
Annovazzi P; Bertolotto A; Brescia Morra V; Gasperini C; Montanari E; Navarra P; Patti F; Sormani MP; Ghezzi A;
Biological activity of glatiramer acetate on Treg and anti-inflammatory monocytes persists for more than 10years in responder multiple sclerosis patients. in Clinical immunology (Orlando, Fla.) / Clin Immunol. 2017 Aug;181:83-88. doi: 10.1016/j.clim.2017.06.006. Epub 2017 Jun 19.
2017
AOU San Luigi di Orbassano
Spadaro M; Montarolo F; Perga S; Martire S; Brescia F; Malucchi S; Bertolotto A;
Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases. in Therapeutic drug monitoring / Ther Drug Monit. 2017 Aug;39(4):339-343. doi: 10.1097/FTD.0000000000000410.
2017
AOU San Luigi di Orbassano
Paintaud G; Passot C; Ternant D; Bertolotto A; Bejan-Angoulvant T; Pascual-Salcedo D; Mulleman D;
Biopharmaceuticals: Reference Products and Biosimilars to Treat Inflammatory Diseases. in Therapeutic drug monitoring / Ther Drug Monit. 2017 Aug;39(4):308-315. doi: 10.1097/FTD.0000000000000385.
2017
AOU San Luigi di Orbassano
Gils A; Bertolotto A; Mulleman D; Bejan-Angoulvant T; Declerck PJ;
The Effectiveness of a Body-Affective Mindfulness Intervention for Multiple Sclerosis Patients with Depressive Symptoms: A Randomized Controlled Clinical Trial. in Frontiers in psychology / Front Psychol. 2017 Nov 30;8:2083. doi: 10.3389/fpsyg.2017.02083. eCollection 2017.
2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Carletto S; Tesio V; Borghi M; Francone D; Scavelli F; Bertino G; Malucchi S; Bertolotto A; Oliva F; Torta R; Ostacoli L;
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. in Frontiers in immunology / Front Immunol. 2017 Mar 23;8:321. doi: 10.3389/fimmu.2017.00321. eCollection 2017.
2017
AOU San Luigi di Orbassano
AO Cuneo
AOU Novara
Chiocchetti A; Dianzani U; Leone M; Sblattero D; Cena T; Ambrogio L; Martinelli-Boneschi F; Caldano M; Bertolotto A; Dianzani C; Sorosina M; Boggio E; Orilieri E; Gigliotti CL; Vecchio D; Cappellano G; Raineri D; Comi C; Clemente N;
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):1005-15. doi: 10.1136/jnnp-2015-312601. Epub 2016 Apr
2016
AOU San Luigi di Orbassano
Waters P; Reindl M; Saiz A; Schanda K; Tuller F; Kral V; Nytrova P; Sobek O; Nielsen HH; Barington T; Lillevang ST; Illes Z; Rentzsch K; Berthele A; Berki T; Granieri L; Bertolotto A; Giometto B; Zuliani L; Hamann D; van Pelt ED; Hintzen R; Höftberger R; Costa C; Comabella M; Montalban X; Tintoré M; Siva A; Altintas A; et alii...
Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients. in Neurotoxicity research / Neurotox Res. 2016 Oct;30(3):338-44. doi: 10.1007/s12640-016-9626-4. Epub 2016 May 9.
2016
AOU San Luigi di Orbassano
ASL Città di Torino
Leotta D; Bertolotto A; Marchet A; Navone DN; Martire S; Perga S; Montarolo F;
A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients. in Journal of neuroimmunology / J Neuroimmunol. 2016 Mar 15;292:34-9. doi: 10.1016/j.jneuroim.2016.01.010. Epub 2016 Jan 16.
2016
AOU San Luigi di Orbassano
Martire S; Navone ND; Montarolo F; Perga S; Bertolotto A;
PML risk stratification using anti-JCV antibody index and L-selectin. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2016 Jul;22(8):1048-60. doi: 10.1177/1352458515607651. Epub 2015 Oct 2.
2016
AOU San Luigi di Orbassano
Schwab N; Schneider-Hohendorf T; Pignolet B; Spadaro M; Görlich D; Meinl I; Windhagen S; Tackenberg B; Breuer J; Cantó E; Kümpfel T; Hohlfeld R; Siffrin V; Luessi F; Posevitz-Fejfár A; Montalban X; Meuth SG; Zipp F; Gold R; Du Pasquier RA; Kleinschnitz C; Jacobi A; Comabella M; Bertolotto A; Brassat D; Wiendl H;
The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial. in BMC neurology / BMC Neurol. 2016 Jan 13;16:7. doi: 10.1186/s12883-016-0528-0.
2016
AOU San Luigi di Orbassano
ASL Città di Torino
ASL Torino 3
Oliva F; Bertolotto A; Malucchi S; Cavallo M; Bertino G; Scavelli F; Francone D; Borghi M; Carletto S; Ostacoli L;
Reversible disconnection syndrome in a case of acute tumefactive demyelinating lesion: a PET study. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2016 Dec;37(12):2019-2023. doi: 10.1007/s10072-016-2675-x. Epub 2016 Jul 25.
2016
AOU San Luigi di Orbassano
Chiavazza C; Cistaro A; Fania P; Bertolotto A; Cavalla P; Rudà R; Pinessi L; Soffietti R;
Cytokine profiles show heterogeneity of interferon-? response in multiple sclerosis patients. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2016 Jan 27;3(2):e202. doi: 10.1212/NXI.0000000000000202. eCollect
2016
AOU San Luigi di Orbassano
Hegen H; Adrianto I; Lessard CJ; Millonig A; Bertolotto A; Comabella M; Giovannoni G; Guger M; Hoelzl M; Khalil M; Fazekas F; Killestein J; Lindberg RL; Malucchi S; Mehling M; Montalban X; Rudzki D; Schautzer F; Sellebjerg F; Sorensen PS; Deisenhammer F; Steinman L; Axtell RC;
Anal sphincter dysfunction in multiple sclerosis: an observation manometric study. in Open medicine (Warsaw, Poland) / Open Med (Wars). 2016 Nov 25;11(1):509-517. doi: 10.1515/med-2016-0088. eCollection 2016.
2016
AOU San Luigi di Orbassano
Marola S; Ferrarese A; Gibin E; Capobianco M; Bertolotto A; Enrico S; Solej M; Martino V; Destefano I; Nano M;
Decline of Neuropsychological Abilities in a Large Sample of Patients with Multiple Sclerosis: A Two-Year Longitudinal Study. in Frontiers in human neuroscience / Front Hum Neurosci. 2016 Jun 8;10:282. doi: 10.3389/fnhum.2016.00282. eCollection 2016.
2016
AOU San Luigi di Orbassano
ASL Città di Torino
ASL Torino 3
Borghi M; Carletto S; Ostacoli L; Scavelli F; Pia L; Pagani M; Bertolotto A; Malucchi S; Signori A; Cavallo M;
Normative Values for Intertrial Variability of Motor Responses to Nerve Root and Transcranial Stimulation: A Condition for Follow-Up Studies in Individual Subjects. in PloS one / PLoS One. 2016 May 16;11(5):e0155268. doi: 10.1371/journal.pone.0155268. eCollection 2016.
2016
AOU San Luigi di Orbassano
Troni W; Melillo F; Bertolotto A; Malucchi S; Capobianco M; Sperli F; Di Sapio A;
Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory. in PloS one / PLoS One. 2016 Apr 14;11(4):e0153466. doi: 10.1371/journal.pone.0153466. eCollection 2016.
2016
AOU San Luigi di Orbassano
Rosato R; Testa S; Bertolotto A; Confalonieri P; Patti F; Lugaresi A; Grasso MG; Toscano A; Giordano A; Solari A;
Evaluation of the impact of neutralizing antibodies on IFN? response. in Clinica chimica acta; international journal of clinical chemistry / Clin Chim Acta. 2015 Sep 20;449:31-6. doi: 10.1016/j.cca.2015.02.043. Epub 2015 Mar 10.
2015
AOU San Luigi di Orbassano
Bertolotto A;
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis. in Brain : a journal of neurology / Brain. 2015 Nov;138(Pt 11):3275-86. doi: 10.1093/brain/awv260. Epub 2015 Sep 11.
2015
AOU San Luigi di Orbassano
Iaffaldano P; Lucisano G; Pozzilli C; Brescia Morra V; Ghezzi A; Millefiorini E; Patti F; Lugaresi A; Zimatore GB; Marrosu MG; Amato MP; Bertolotto A; Bergamaschi R; Granella F; Coniglio G; Tedeschi G; Sola P; Lus G; Ferrò MT; Iuliano G; Corea F; Protti A; Cavalla P; Guareschi A; Rodegher M; Paolicelli D; Tortorella C; Lepore V; Prosperini L; et alii...
Nurr1 reduction influences the onset of chronic EAE in mice. in Inflammation research : official journal of the European Histamine Research Society ... [et al.] / Inflamm Res. 2015 Nov;64(11):841-4. doi: 10.1007/s00011-015-0871-4. Epub 2015 Sep 4.
2015
AOU San Luigi di Orbassano
Montarolo F; Perga S; Martire S; Bertolotto A;
No impact of current therapeutic strategies on disease reactivation after natalizumab discontinuation: a comparative analysis of different approaches during the first year of natalizumab discontinuation. in European journal of neurology / Eur J Neurol. 2015 Mar;22(3):585-7. doi: 10.1111/ene.12487. Epub 2014 Jul 3.
2015
AOU San Luigi di Orbassano
Capobianco M; di Sapio A; Malentacchi M; Malucchi S; Matta M; Sperli F; Bertolotto A;
Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-? Therapy. in Neurology and therapy / Neurol Ther. 2015 Jun;4(1):53-60. doi: 10.1007/s40120-015-0027-z. Epub 2015 Mar 6.
2015
AOU San Luigi di Orbassano
Motuzova Y; Di Sapio A; Capobianco M; Sala A; Marnetto F; Malucchi S; Bertolotto A;
Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis. in Journal of neuroinflammation / J Neuroinflammation. 2015 Jul 14;12:132. doi: 10.1186/s12974-015-0353-1.
2015
AOU San Luigi di Orbassano
Veroni C; Marnetto F; Granieri L; Bertolotto A; Ballerini C; Repice AM; Schirru L; Coghe G; Cocco E; Anastasiadou E; Puopolo M; Aloisi F;
Anti-inflammatory genes associated with multiple sclerosis: a gene expression study. in Journal of neuroimmunology / J Neuroimmunol. 2015 Feb 15;279:75-8. doi: 10.1016/j.jneuroim.2015.01.004. Epub 2015 Jan 21.
2015
AOU San Luigi di Orbassano
Perga S; Montarolo F; Martire S; Berchialla P; Malucchi S; Bertolotto A;
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers. in Neurology and therapy / Neurol Ther. 2015 Dec;4(2):147-57. doi: 10.1007/s40120-015-0038-9. Epub 2015 Dec 8.
2015
AOU San Luigi di Orbassano
Lo Re M; Capobianco M; Ragonese P; Realmuto S; Malucchi S; Berchialla P; Salemi G; Bertolotto A;
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells. in Journal of neuroinflammation / J Neuroinflammation. 2015 Aug 12;12:146. doi: 10.1186/s12974-015-0365-x.
2015
AOU San Luigi di Orbassano
Spadaro M; Caldano M; Marnetto F; Lugaresi A; Bertolotto A;
Biological monitoring of IFN-? therapy in Multiple Sclerosis. in Cytokine & growth factor reviews / Cytokine Growth Factor Rev. 2015 Apr;26(2):241-8. doi: 10.1016/j.cytogfr.2014.12.002. Epub 2014 Dec
2015
AOU San Luigi di Orbassano
Bertolotto A; Granieri L; Marnetto F; Valentino P; Sala A; Capobianco M; Malucchi S; Di Sapio A; Malentacchi M; Matta M; Caldano M;
Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis. in PloS one / PLoS One. 2015 Jun 5;10(6):e0129291. doi: 10.1371/journal.pone.0129291. eCollection 2015.
2015
AOU San Luigi di Orbassano
Perga S; Giuliano Albo A; Lis K; Minari N; Falvo S; Marnetto F; Caldano M; Reviglione R; Berchialla P; Capobianco MA; Malentacchi M; Corpillo D; Bertolotto A;
Monocytes and CD4+ T cells contribution to the under-expression of NR4A2 and TNFAIP3 genes in patients with multiple sclerosis. in Journal of neuroimmunology / J Neuroimmunol. 2014 Jul 15;272(1-2):99-102. doi: 10.1016/j.jneuroim.2014.04.017. Epub 2014 May 10.
2014
AOU San Luigi di Orbassano
Navone ND; Perga S; Martire S; Berchialla P; Malucchi S; Bertolotto A;
A new neurophysiological approach to assess central motor conduction damage to proximal and distal muscles of lower limbs. in Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology / Clin Neurophysiol. 2014 Jan;125(1):133-41. doi: 10.1016/j.clinph.2013.06.018. Epub 2013 Jul 16.
2014
AOU San Luigi di Orbassano
Di Sapio A; Bertolotto A; Melillo F; Sperli F; Malucchi S; Troni W;
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2014 Feb;35(2):307-16. doi: 10.1007/s10072-013-1616-1. Epub 2013 Dec 29.
2014
AOU San Luigi di Orbassano
Bertolotto A; Capobianco M; Amato MP; Capello E; Capra R; Centonze D; Di Ioia M; Gallo A; Grimaldi L; Imberti L; Lugaresi A; Mancinelli C; Marrosu MG; Moiola L; Montanari E; Romano S; Musu L; Paolicelli D; Patti F; Pozzilli C; Rossi S; Salvetti M; Tedeschi G; Tola MR; Trojano M; Zaffaroni M; Malucchi S;
CD19 mRNA quantification improves rituximab treatment-to-target approach: a proof of concept study. in Journal of neuroimmunology / J Neuroimmunol. 2014 Dec 15;277(1-2):127-33. doi: 10.1016/j.jneuroim.2014.09.008. Epub 2014 Sep 20.
2014
AOU San Luigi di Orbassano
Marnetto F; Granieri L; Valentino P; Capobianco M; Pautasso M; Bertolotto A;
Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice. in PloS one / PLoS One. 2014 Sep 29;9(9):e108791. doi: 10.1371/journal.pone.0108791. eCollection 2014.
2014
AOU San Luigi di Orbassano
Montarolo F; Raffaele C; Perga S; Martire S; Finardi A; Furlan R; Hintermann S; Bertolotto A;
Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy's Adherence, Hospital Reliability's Perception, and Services Provided Quality. in Multiple sclerosis international / Mult Scler Int. 2014;2014:752318. doi: 10.1155/2014/752318. Epub 2014 Aug 26.
2014
AOU San Luigi di Orbassano
Di Battista G; Bertolotto A; Gasperini C; Ghezzi A; Maimone D; Solaro C;
Prevalence and significant determinants of post-traumatic stress disorder in a large sample of patients with multiple sclerosis. in Journal of clinical psychology in medical settings / J Clin Psychol Med Settings. 2013 Jun;20(2):240-6. doi: 10.1007/s10880-012-9323-2.
2013
AOU San Luigi di Orbassano
ASL Torino 3
Ostacoli L; Carletto S; Borghi M; Cavallo M; Rocci E; Zuffranieri M; Malucchi S; Bertolotto A; Zennaro A; Furlan PM; Picci RL;
Presence and significant determinants of cognitive impairment in a large sample of patients with multiple sclerosis. in PloS one / PLoS One. 2013 Jul 29;8(7):e69820. doi: 10.1371/journal.pone.0069820. Print 2013.
2013
AOU San Luigi di Orbassano
ASL Torino 3
Borghi M; Cavallo M; Carletto S; Ostacoli L; Zuffranieri M; Picci RL; Scavelli F; Johnston H; Furlan PM; Bertolotto A; Malucchi S;
A methodological reappraisal to restrain intra-trial MEP area variability in Neurology
2013
AOU San Luigi di Orbassano
Di Sapio A; Melillo F; Malucchi S; Bertolotto A; Troni V;
Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-? and interleukin-4 response. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2012 Oct;18(10):1484-92. doi: 10.1177/1352458512440349. Epub 2012 May 4.
2012
AOU San Luigi di Orbassano
Gilli F; Navone ND; Valentino P; Granieri L; Perga S; Malucchi S; Bertolotto A;
Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2012 Aug;33(4):863-7. doi: 10.1007/s10072-011-0848-1. Epub 2011 Nov 25.
2012
AOU San Luigi di Orbassano
Capobianco M; Motuzova Y; Frau J; Cocco E; Mamusa E; Marrosu MG; Bertolotto A;
Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology. in PloS one / PLoS One. 2012;7(6):e38896. doi: 10.1371/journal.pone.0038896. Epub 2012 Jun 12.
2012
AOU San Luigi di Orbassano
Granieri L; Marnetto F; Valentino P; Frau J; Patanella AK; Nytrova P; Sola P; Capobianco M; Jarius S; Bertolotto A;
Association of genetic markers with the presence of cerebrospinal fluid oligoclonal bands in the Italian population in Multiple Sclerosis
2012
AOU San Luigi di Orbassano
Barrizzone N; Leone MA; Esposito F; Lucenti A; Harbo HF; Goris A; Kockum I; Oturai AB; Celius EG; Mero IL; Dubois B; Olsson T; Søndergaard HB; Cusi D; Lupoli S; Guerini F; Galimberti D; Salvetti M; Liberatore G; Naldi P; Myhr K-M; Bergamaschi R; Comi G; Martinelli Boneschi F; D'Alfonso S; Marnetto F; Caldano M; Sala A; Malucchi S; et alii...
A methodological reappraisal of non invasive high voltage electrical stimulation of lumbosacral nerve roots. in Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology / Clin Neurophysiol. 2011 Oct;122(10):2071-80. doi: 10.1016/j.clinph.2011.03.002. Epub 2011 Mar 31.
2011
AOU San Luigi di Orbassano
Troni W; Di Sapio A; Berra E; Duca S; Merola A; Sperli F; Bertolotto A;
One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients. in Journal of neurology / J Neurol. 2011 May;258(5):895-903. doi: 10.1007/s00415-010-5844-5. Epub 2010 Dec 12.
2011
AOU San Luigi di Orbassano
Malucchi S; Gilli F; Caldano M; Sala A; Capobianco M; di Sapio A; Granieri L; Bertolotto A;
Loss of braking signals during inflammation: a factor affecting the development and disease course of multiple sclerosis. in Archives of neurology / Arch Neurol. 2011 Jul;68(7):879-88. doi: 10.1001/archneurol.2011.32. Epub 2011 Mar 14.
2011
AOU San Luigi di Orbassano
Gilli F; Navone ND; Perga S; Marnetto F; Caldano M; Capobianco M; Pulizzi A; Malucchi S; Bertolotto A;
Peripheral and central (CCT) conduction times to proximal and distal muscles of lower limbs: Methodological aspects and clinical application in MS patients in Clinical Neurophysiology
2011
AOU San Luigi di Orbassano
Di Sapio A; Pulizzi A; Sperli F; Bertolotto A; Troni W;
Direct current stimulation and neuromuscular transmission in man in Clinical Neurophysiology
2011
AOU San Luigi di Orbassano
Troni W; Di Sapio A; Sperli F; Bertolotto A; Delfico L; Ferrero B;
Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. in PloS one / PLoS One. 2010 Jan 29;5(1):e8962. doi: 10.1371/journal.pone.0008962.
2010
AOU San Luigi di Orbassano
Gilli F; Lindberg RL; Valentino P; Marnetto F; Malucchi S; Sala A; Capobianco M; di Sapio A; Sperli F; Kappos L; Calogero RA; Bertolotto A;
Implications of neutralising antibodies on therapeutic efficacy. in Journal of the neurological sciences / J Neurol Sci. 2009 Feb 1;277 Suppl 1:S29-32. doi: 10.1016/S0022-510X(09)70009-7.
2009
AOU San Luigi di Orbassano
Bertolotto A;
Western blot analysis for the detection of serum antibodies recognizing linear Aquaporin-4 epitopes in patients with Neuromyelitis Optica. in Journal of neuroimmunology / J Neuroimmunol. 2009 Dec 10;217(1-2):74-9. doi: 10.1016/j.jneuroim.2009.10.002. Epub 2009 Oct 21.
2009
AOU San Luigi di Orbassano
Marnetto F; Hellias B; Granieri L; Frau J; Patanella AK; Nytrova P; Sala A; Capobianco M; Gilli F; Bertolotto A;
High incidence of acute leukaemia in multiple sclerosis patients treated with mitoxantrone: A retrospective multicentre Italian study in Journal of the Neurological Sciences
2009
AOU San Luigi di Orbassano
Martinelli V; Capra R; Gasperini C; Cocco E; Bellantonio P; Pesci I; Bertolotto A; Gallo P; Amato MP; Ghezzis A; Grimaldi L; Lugaresi A; Mancardi G; Bergamaschi R; Ponzio M; Pozzilli C; Salemi G; Trojano M; Rodegher ME; Straffi L; Comi G;
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: The Italian experience in Neurological Sciences
2009
AOU San Luigi di Orbassano
Ghezzi A; Amato MP; Annovazzi P; Capobianco M; Gallo P; La Mantia L; Marrosu MG; Martinelli V; Milani N; Moiola L; Patti F; Pozzilli C; Trojano M; Zaffaroni M; Comi G; Simone IL; Di Monte E; Ardito R; Stecchi S; Scandellari C; Marrosu MG; Spinicci G; Patti F; D'Amico E; Portaccio E; Lori S; Costantino GF; Pilato V; Zaffaroni M; et alii...
Glatiramer acetate is a treatment option in neutralising antibodies to interferon-beta-positive patients. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2008 Sep;29 Suppl 2:S227-9. doi: 10.1007/s10072-008-0945-y.
2008
AOU San Luigi di Orbassano
Capobianco M; Rizzo A; Malucchi S; Sperli F; Di Sapio A; Oggero A; Zaffaroni M; Ghezzi A; Bertolotto A;
Interferon-beta responders and non-responders. A biological approach. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2008 Sep;29 Suppl 2:S216-7. doi: 10.1007/s10072-008-0941-2.
2008
AOU San Luigi di Orbassano
Bertolotto A; Gilli F;
Predictive markers for response to interferon therapy in patients with multiple sclerosis. in Neurology / Neurology. 2008 Mar 25;70(13 Pt 2):1119-27. doi: 10.1212/01.wnl.0000304040.29080.7b. Epub 2008 Feb 1
2008
AOU San Luigi di Orbassano
Malucchi S; Gilli F; Caldano M; Marnetto F; Valentino P; Granieri L; Sala A; Capobianco M; Bertolotto A;
Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosis. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2008 Jun;29(3):185-7. doi: 10.1007/s10072-008-0934-1. Epub 2008 Jul 9.
2008
AOU San Luigi di Orbassano
Capobianco M; Malucchi S; Ulisciani S; Fava C; Cambrin GR; Avonto L; Saglio G; Bertolotto A;
Development of a bioassay for quantification of neutralising antibodies against human interferon-beta in mouse sera. in Journal of immunological methods / J Immunol Methods. 2008 Jul 31;336(2):119-26. doi: 10.1016/j.jim.2008.04.002. Epub 2008 Apr 28.
2008
AOU San Luigi di Orbassano
Gilli F; van Beers M; Marnetto F; Jiskoot W; Bertolotto A; Schellekens H;
Expression and regulation of IFNalpha/beta receptor in IFNbeta-treated patients with multiple sclerosis. in Neurology / Neurology. 2008 Dec 9;71(24):1940-7. doi: 10.1212/01.wnl.0000327340.50284.8d. Epub 2008 Oct 29.
2008
AOU San Luigi di Orbassano
Gilli F; Valentino P; Caldano M; Granieri L; Capobianco M; Malucchi S; Sala A; Marnetto F; Bertolotto A;
Anti-interferon-beta neutralising activity is not entirely mediated by antibodies. in Journal of neuroimmunology / J Neuroimmunol. 2007 Dec;192(1-2):198-205. doi: 10.1016/j.jneuroim.2007.09.025. Epub 2007 Oct 22.
2007
AOU San Luigi di Orbassano
Gilli F; Marnetto F; Caldano M; Valentino P; Granieri L; Di Sapio A; Capobianco M; Sala A; Malucchi S; Kappos L; Lindberg RL; Bertolotto A;
Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease). in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2007 Aug;28(4):209-11. doi: 10.1007/s10072-007-0823-z. Epub 2007 Aug 10.
2007
AOU San Luigi di Orbassano
Capobianco M; Malucchi S; di Sapio A; Gilli F; Sala A; Bottero R; Marnetto F; Doriguzzi Bozzo C; Bertolotto A;
Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta. in Journal of immunological methods / J Immunol Methods. 2007 Apr 10;321(1-2):19-31. doi: 10.1016/j.jim.2006.12.012. Epub 2007 Feb 20.
2007
AOU San Luigi di Orbassano
Bertolotto A; Sala A; Caldano M; Capobianco M; Malucchi S; Marnetto F; Gilli F;
Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2006 Feb;12(1):47-57. doi: 10.1191/135248506ms1245oa.
2006
AOU San Luigi di Orbassano
Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Capobianco M; Bertolotto A;
Qualitative and quantitative analysis of antibody response against IFNbeta in patients with multiple sclerosis. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2006 Dec;12(6):738-46. doi: 10.1177/1352458506070968.
2006
AOU San Luigi di Orbassano
Gilli F; Hoffmann F; Sala A; Marnetto F; Caldano M; Valentino P; Kappos L; Bertolotto A; Lindberg RL;
Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis. in Journal of neuroimmunology / J Neuroimmunol. 2005 Jan;158(1-2):195-203. doi: 10.1016/j.jneuroim.2004.08.006.
2005
AOU San Luigi di Orbassano
Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Di Sapio A; Capobianco M; Bertolotto A;
Fate of multiple sclerosis patients positive for neutralising antibodies towards interferon beta shifted to alternative treatments. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2005 Dec;26 Suppl 4:S213-4. doi: 10.1007/s10072-005-0517-3.
2005
AOU San Luigi di Orbassano
Malucchi S; Capobianco M; Gilli F; Marnetto F; Caldano M; Sala A; Bertolotto A;
Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1294-9. doi: 10.1136/jnnp.2004.037259.
2004
AOU San Luigi di Orbassano
Bertolotto A; Sala A; Malucchi S; Marnetto F; Caldano M; Di Sapio A; Capobianco M; Gilli F;
Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis. in Neurology / Neurology. 2004 Jun 8;62(11):2031-7. doi: 10.1212/01.wnl.0000129265.73259.9e.
2004
AOU San Luigi di Orbassano
Malucchi S; Sala A; Gilli F; Bottero R; Di Sapio A; Capobianco M; Bertolotto A;
Immunogenicity of interferon beta: differences among products. in Journal of neurology / J Neurol. 2004 Jun;251 Suppl 2:II15-II24. doi: 10.1007/s00415-004-1204-7.
2004
AOU San Luigi di Orbassano
Bertolotto A; Deisenhammer F; Gallo P; Sölberg Sørensen P;
Neutralizing antibodies to interferon beta: implications for the management of multiple sclerosis. in Current opinion in neurology / Curr Opin Neurol. 2004 Jun;17(3):241-6. doi: 10.1097/00019052-200406000-00002.
2004
AOU San Luigi di Orbassano
Bertolotto A;
Comparison of three PCR assays for the evaluation of interferon-beta biological activity in patients with multiple sclerosis. in Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology / Mol Diagn. 2004;8(3):185-94. doi: 10.1007/BF03260063.
2004
AOU San Luigi di Orbassano
Gilli F; Marnetto F; Stefanuto G; Rinaldi V; Farinazzo F; Malucchi S; Capobianco M; Caldano M; Sala A; Bertolotto A;
Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2003 Oct;24(3):130-3. doi: 10.1007/s10072-003-0098-y.
2003
AOU San Luigi di Orbassano
Milano E; Di Sapio A; Malucchi S; Capobianco M; Bottero R; Sala A; Gilli F; Bertolotto A;
Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients. in Neurology / Neurology. 2003 Feb 25;60(4):634-9. doi: 10.1212/01.wnl.0000046662.03894.c5.
2003
AOU San Luigi di Orbassano
Bertolotto A; Gilli F; Sala A; Capobianco M; Malucchi S; Milano E; Melis F; Marnetto F; Lindberg RL; Bottero R; Di Sapio A; Giordana MT;
Necrotizing skin lesions and NABs development in a multiple sclerosis patient treated with IFN? 1b in Multiple Sclerosis
2003
AOU San Luigi di Orbassano
Casoni F; Merelli E; Bedin R; Martella A; Cesinaro A; Bertolotto A;
Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2002 Aug;73(2):148-53. doi: 10.1136/jnnp.73.2.148.
2002
AOU San Luigi di Orbassano
Bertolotto A; Malucchi S; Sala A; Orefice G; Carrieri PB; Capobianco M; Milano E; Melis F; Giordana MT;
Evaluation of IFNalpha bioavailability by MxA mRNA in HCV patients. in Journal of immunological methods / J Immunol Methods. 2002 Apr 1;262(1-2):187-90. doi: 10.1016/s0022-1759(02)00008-x.
2002
AOU San Luigi di Orbassano
Gilli F; Sala A; Bancone C; Salacone P; Gallo M; Gaia E; Bertolotto A;
Evaluation of bioavailability of three types of IFNbeta in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification. in Journal of immunological methods / J Immunol Methods. 2001 Oct 1;256(1-2):141-52. doi: 10.1016/s0022-1759(01)00434-3.
2001
AOU San Luigi di Orbassano
Bertolotto A; Gilli F; Sala A; Audano L; Castello A; Magliola U; Melis F; Giordana MT;
Interferon beta neutralizing antibodies in multiple sclerosis: neutralizing activity and cross-reactivity with three different preparations. in Immunopharmacology / Immunopharmacology. 2000 Jul 20;48(2):95-100. doi: 10.1016/s0162-3109(00)00182-x.
2000
AOU San Luigi di Orbassano
Bertolotto A; Malucchi S; Milano E; Castello A; Capobianco M; Mutani R;
Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients. in Neuroscience letters / Neurosci Lett. 1999 Mar 19;263(1):21-4. doi: 10.1016/s0304-3940(99)00102-0.
1999
AOU San Luigi di Orbassano
Bertolotto A; Capobianco M; Malucchi S; Manzardo E; Audano L; Bergui M; Bradac GB; Mutani R;
Quantitative PCR reveals increased levels of tumor necrosis factor-alpha mRNA in peripheral blood mononuclear cells of multiple sclerosis patients during relapses. in Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research / J Interferon Cytokine Res. 1999 Jun;19(6):575-81. doi: 10.1089/107999099313703.
1999
AOU San Luigi di Orbassano
Bertolotto A; Malucchi S; Capobianco M; Manzardo E; Guastamacchia G; Milano E; Audano L; Mutani R;
5D4 keratan sulfate epitope identifies a subset of ramified microglia in normal central nervous system parenchyma. in Journal of neuroimmunology / J Neuroimmunol. 1998 May 1;85(1):69-77. doi: 10.1016/s0165-5728(97)00251-8.
1998
AOU San Luigi di Orbassano
Bertolotto A; Agresti C; Castello A; Manzardo E; Riccio A;
Keratan sulphate is a marker of differentiation of ramified microglia. in Brain research. Developmental brain research / Brain Res Dev Brain Res. 1995 May 26;86(1-2):233-41. doi: 10.1016/0165-3806(95)00030-h.
1995
AOU San Luigi di Orbassano
Bertolotto A; Manzardo E; Iudicello M; Guglielmone R; Riccio A;
Disappearance of the Vicia villosa-positivity from the perineuronal net containing chondroitin proteoglycan after chondroitinase digestion. in Brain research / Brain Res. 1995 Mar 6;673(2):344-8. doi: 10.1016/0006-8993(95)00015-i.
1995
AOU San Luigi di Orbassano
Bertolotto A; Manzardo E; Iudicello M; Lovisetto C; Riccio A;